Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;9(5):1249-1304.
doi: 10.1007/s40744-022-00475-4. Epub 2022 Jul 18.

Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review

Affiliations
Review

Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review

Sara Momtazmanesh et al. Rheumatol Ther. 2022 Oct.

Abstract

Investigation of the potential applications of artificial intelligence (AI), including machine learning (ML) and deep learning (DL) techniques, is an exponentially growing field in medicine and healthcare. These methods can be critical in providing high-quality care to patients with chronic rheumatological diseases lacking an optimal treatment, like rheumatoid arthritis (RA), which is the second most prevalent autoimmune disease. Herein, following reviewing the basic concepts of AI, we summarize the advances in its applications in RA clinical practice and research. We provide directions for future investigations in this field after reviewing the current knowledge gaps and technical and ethical challenges in applying AI. Automated models have been largely used to improve RA diagnosis since the early 2000s, and they have used a wide variety of techniques, e.g., support vector machine, random forest, and artificial neural networks. AI algorithms can facilitate screening and identification of susceptible groups, diagnosis using omics, imaging, clinical, and sensor data, patient detection within electronic health record (EHR), i.e., phenotyping, treatment response assessment, monitoring disease course, determining prognosis, novel drug discovery, and enhancing basic science research. They can also aid in risk assessment for incidence of comorbidities, e.g., cardiovascular diseases, in patients with RA. However, the proposed models may vary significantly in their performance and reliability. Despite the promising results achieved by AI models in enhancing early diagnosis and management of patients with RA, they are not fully ready to be incorporated into clinical practice. Future investigations are required to ensure development of reliable and generalizable algorithms while they carefully look for any potential source of bias or misconduct. We showed that a growing body of evidence supports the potential role of AI in revolutionizing screening, diagnosis, and management of patients with RA. However, multiple obstacles hinder clinical applications of AI models. Incorporating the machine and/or deep learning algorithms into real-world settings would be a key step in the progress of AI in medicine.

Keywords: Artificial intelligence; Autoimmune diseases; Deep learning; Diagnosis; Imaging; Machine learning; Natural language processing; Precision medicine; Rheumatoid arthritis; Treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The variety of input data sources for artificial intelligence (AI) models, CT computed tomography, MRI magnetic resonance imaging, US ultrasound
Fig. 2
Fig. 2
Evolution of artificial intelligence, machine learning, and deep learning
Fig. 3
Fig. 3
The role of artificial intelligence (AI) in enhanced diagnosis and management of rheumatoid arthritis (RA)

Similar articles

Cited by

References

    1. Artificial intelligence. https://www.merriam-webster.com/dictionary/artificial%20intelligence. Accessed 15 Feb 2022.
    1. Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism. 2017;69S:S36–S40. doi: 10.1016/j.metabol.2017.01.011. - DOI - PubMed
    1. Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol. 2019;20:e253–e261. doi: 10.1016/S1470-2045(19)30154-8. - DOI - PMC - PubMed
    1. Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts H. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500–510. doi: 10.1038/s41568-018-0016-5. - DOI - PMC - PubMed
    1. Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, Zhao S. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18:463–477. doi: 10.1038/s41573-019-0024-5. - DOI - PMC - PubMed

LinkOut - more resources